We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$393M
AUM Growth
+$34.5M
Cap. Flow
+$5.89M
Cap. Flow %
1.5%
Top 10 Hldgs %
23.79%
Holding
1,179
New
38
Increased
165
Reduced
258
Closed
39

Top Buys

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$2.92M
2
UNH icon
UnitedHealth
UNH
+$1.26M
3
MSFT icon
Microsoft
MSFT
+$1.18M
4
T icon
AT&T
T
+$795K
5
JPM icon
JPMorgan Chase
JPM
+$780K

Sector Composition

Rank Sector Weight
1 Technology 22.29%
2 Healthcare 13.57%
3 Financials 12.77%
4 Consumer Discretionary 8.62%
5 Communication Services 7.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELGZ
1176
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
-3,656
Closed -$4K
VIA
1177
DELISTED
Viacom Inc. Class A
VIA
-1,454
Closed -$40K
CELG
1178
DELISTED
Celgene Corp
CELG
-7,072
Closed -$704K
AUO
1179
DELISTED
AU Optronics Corp
AUO
-10
Closed -$2K

Similar funds

Winslow Evans & Crocker's Q4 2019 Portfolio in Review

As of Q4 2019, Winslow Evans & Crocker held 1,179 positions worth $393M, up 9.6% from $358M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Winslow Evans & Crocker's Q4 2019 filing shows 38 new, 165 increased, 258 reduced and 39 closed positions. Its largest new stake was Kansas City Southern: 2,476 shares worth $380K. The largest sale was Celgene Corp, an estimated $704K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Winslow Evans & Crocker's largest Q4 2019 buy was Kansas City Southern: 2,476 shares worth $380K.
  • Winslow Evans & Crocker added most to Global Payments in Q4 2019, an estimated $2.92M increase.
  • Winslow Evans & Crocker's biggest Q4 2019 reduction was Akamai, cutting an estimated $461K.
  • Winslow Evans & Crocker fully exited Celgene Corp in Q4 2019, selling an estimated $704K.
  • Winslow Evans & Crocker's ten largest holdings make up 24% of its $393M portfolio in Q4 2019.
  • Winslow Evans & Crocker opened 38 new positions and closed 39 in Q4 2019.
  • Winslow Evans & Crocker's portfolio value rose 9.6% quarter-over-quarter to $393M.

Based on Winslow Evans & Crocker's 13F filing for Q4 2019, filed 14 Jan 2020.